The Valley Desk

ArticleClinical genitourinary cancerPublished

Preferred Treatment Sequencing for Metastatic Urothelial Carcinoma (mUC) in the Era of Perioperative and First-Line (1L) Checkpoint Inhibitor: Results From a National Survey of Genitourinary Oncologists

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Clinical genitourinary cancer
Published
Subject terms
Humans; Carcinoma, Transitional Cell; Antibodies, Monoclonal; United States; Female; Male; Urinary Bladder Neoplasms; Antibodies, Monoclonal, Humanized; Surveys and Questionnaires; Practice Patterns, Physicians'; Oncologists; Immune Checkpoint Inhibitors
PubMed ID
41582039
Added to directory
Source checked

Report a correction or request removal